EyePoint Pharmaceuticals Inc (EYPT)
NASDAQ
Quarter End | 9 2022 | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 10.01M | 10.53M | 7.68M | 9.11M | 15.2M | 14.03M | 11.68M | 9.48M |
営業利益 | -18.4M | -43.74M | -21.55M | -22.23M | -14.93M | -16.35M | -33.32M | -34.55M |
税引前収入 | -18.42M | -43.45M | -21.16M | -22.92M | -12.61M | -14.02M | -29.28M | -30.83M |
純利益 | -18.42M | -43.45M | -21.16M | -22.92M | -12.61M | -14.1M | -29.28M | -30.83M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -18.4M | -43.74M | -21.55M | -22.23M | -14.93M | -16.35M | -33.32M | -34.55M |
EBITDA | -17.69M | -22.7M | -21.45M | -22.1M | -14.82M | -16.24M | -33.02M | -34.18M |
年末 2023年12月31日 | 2017 | 2018 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 7.54M | 2.96M | 2.93M | 20.37M | 34.44M | 36.94M | 41.4M | 46.02M |
営業利益 | -18.58M | -26.27M | -24.56M | -47.86M | -37.29M | -55.28M | -99.64M | -75.07M |
税引前収入 | -18.49M | -53.17M | -44.72M | -56.79M | -45.39M | -58.42M | -102.25M | -70.71M |
純利益 | -18.49M | -53.17M | -44.72M | -56.79M | -45.39M | -58.42M | -102.25M | -70.8M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -0.031 | -0.083 | -0.068 | -0.084 | -0.078 | -0.098 | -0.17 | -0.118 |
EBIT | -18.58M | -52.55M | -24.56M | -51.67M | -38.2M | -55.28M | -99.64M | -75.07M |
EBITDA | -17.76M | -25.13M | -23.23M | -45.26M | -34.64M | -52.51M | -76.49M | -74.6M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約